CVE-2025-14956A vulnerability was determined in WebAssembly Binaryen up to 125.
Updated under an hour ago ()
Does this affect you?
It affects webassembly binaryen. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A vulnerability was determined in WebAssembly Binaryen up to 125. Affected by this issue is the function WasmBinaryReader::readExport of the file src/wasm/wasm-binary.cpp. This manipulation causes heap-based buffer overflow. It is possible to launch the attack on the local host. The exploit has been publicly disclosed and may be utilized. Patch name: 4f52bff8c4075b5630422f902dd92a0af2c9f398. It is recommended to apply a patch to fix this issue.
- CVSS
- 7.1 HIGH (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:H
- Weakness (CWE)
- CWE-119, CWE-122, CWE-125
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Modified
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
webassembly binaryen webassembly:binaryen | through 125 | NVD |
References
- https://github.com/WebAssembly/binaryen/
- https://github.com/WebAssembly/binaryen/commit/4f52bff8c4075b5630422f902dd92a0af2c9f398patch
- https://github.com/WebAssembly/binaryen/issues/8089exploit, issue-tracking, third-party-advisory
- https://github.com/WebAssembly/binaryen/pull/8092issue-tracking
- https://github.com/oneafter/1204/blob/main/hbfnot-applicable
- https://vuldb.com/?ctiid.337592permissions-required, vdb-entry
- https://vuldb.com/?id.337592third-party-advisory, vdb-entry
- https://vuldb.com/?submit.717315exploit, third-party-advisory, vdb-entry
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.